Prognostic value of cathepsins B, D and stefins A and B in laryngeal carcinoma

European Archives of Oto-Rhino-Laryngology

Volumn 254, Issue SUPPL. 1, 1997, Pages

  Smid L ^a   Strojan, P ^b   Budihna, M ^b   Skrk J ^b   Vrhovec, I ^b   Zargi M ^a   Kos, J ^c,d  

^a Univ Dept of Otorhinolaryngology   (Slovenia)

^b INSTITUTE OF ONCOLOGY   (Slovenia)

^c JO EF STEFAN INSTITUTE   (Slovenia)

^d Research and Development Division   (Slovenia)

Author keywords

Cathepsins B, D; Laryngeal carcinoma; Prognosis; Stefins A, B

Indexed keywords

CATHEPSIN; CATHEPSIN B; CATHEPSIN D; STEFIN; STEFIN A; STEFIN B;

ADULT; AGED; CANCER STAGING; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; LARYNX CARCINOMA; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TISSUE LEVEL;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CATHEPSIN B; CATHEPSIN D; CYSTATINS; CYSTEINE PROTEINASE INHIBITORS; DISEASE-FREE SURVIVAL; HUMANS; LARYNGEAL NEOPLASMS; LARYNX; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0031038953     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02439748     Document Type: Conference Paper

References (14)

1. Azzopardi JG, Chepizk OF, Hartman WH (1981) International histological classification of tumours no. 2: histological typing of breast tumours, 2nd edn. World Health Organization, Geneva
2. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254
3. EORTC Breast Cancer Cooperative Group (1980) Revision of the standards for the assessments of hormone receptors in human breast cancer. Eur J Cancer 16: 1513-1515
4. Harmanek P, Sobin LH (1992) TNM Classification of malignant tumours. International Union Against Cancer (UICC). 4th edn. Springer, Berlin Heidelberg New York
5. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481
6. Kos J, Šmid A, Kraševec M, Svetic B, Lenarćić B, Vrhovec I, Škrk J, Turk V (1995) Lysosomal proteases cathepsins D, B, H, L and their inhibitors stefins A and B in head and neck cancer. Biol Chem Hoppe-Seyler 376: 401-405
7. Lah TT, Clifford JL, Helmer KM, Day NA, Moin K, Honn KV, Crissman JD, Sloane BF (1989) Inhibitory properties of low molecular mass cysteine proteinase inhibitors from human sarcoma. Biochem Biophys Acta 993: 63-73
8. Marsigliante S, Resta L, Leo G, Mazzotta D, d'Amore R, Biscozzo L, Storelli C (1993) Expression of cathepsin D in malignant and in the corresponding non-malignant node-negative laryngeal samples: correlation with receptors for androgen, glucocorticoid, oestrogen and progesterone. Cancer Lett 68: 135-142
9. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35: 1-39
10. Schmitt M, Jänicke F, Graeff H (1992) Tumor-associated proteases. Fibrinolysis 6: 3-26
11. Siewinski M, Krecicki T, Jarmulowicz J, Berdowska I (1992) Cysteine proteinase inhibitors in serum of patients with head and neck tumors. Diagn Oncol 2: 323-326
12. Sloane BF, Moin K, Lah TT (1994) Regulation of lysosomal endopeptidases in malignant neoplasia. In: Pretlow TG, Pretlow TP (eds) Biochemical and molecular aspects of selected cancers, vol II. Academic Press, New York, pp 411-472
13. Strojan P (1996) Cathepsins and their endogenous inhibitors in clinical oncology. Radiol Oncol 30: 120-133
14. Zeillinger R, Swoboda H, Machacek E, Nekahm D, Sliutz G, Knogler W, Speiser P, Swoboda E, Kubista E (1992) Expression of cathepsin D in head and neck cancer. Eur J Cancer 28 A: 1413-1415